Hwang C - Search Results

1

X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer model.

Hwang C, Oetjen KA, Kosoff D, Wojno KJ, Albertelli MA, Dunn RL, Robins DM, Cooney KA, Duckett CS. Hwang C, et al. Cell Death Differ. 2008 May;15(5):831-40. doi: 10.1038/cdd.2008.15. Epub 2008 Feb 8. Cell Death Differ. 2008. PMID: 18259199 Free PMC article.

2

EZH2 regulates the transcription of estrogen-responsive genes through association with REA, an estrogen receptor corepressor.

Hwang C, Giri VN, Wilkinson JC, Wright CW, Wilkinson AS, Cooney KA, Duckett CS. Hwang C, et al. Breast Cancer Res Treat. 2008 Jan;107(2):235-42. doi: 10.1007/s10549-007-9542-7. Epub 2007 Apr 24. Breast Cancer Res Treat. 2008. PMID: 17453341

3

Cytoprotective effects of IAPs revealed by a small molecule antagonist.

Galbán S, Hwang C, Rumble JM, Oetjen KA, Wright CW, Boudreault A, Durkin J, Gillard JW, Jaquith JB, Morris SJ, Duckett CS. Galbán S, et al. Among authors: hwang c. Biochem J. 2009 Feb 1;417(3):765-71. doi: 10.1042/BJ20081677. Biochem J. 2009. PMID: 18851715 Free PMC article.

4

Angiogenesis inhibitors in the treatment of prostate cancer.

Hwang C, Heath EI. Hwang C, et al. J Hematol Oncol. 2010 Aug 2;3:26. doi: 10.1186/1756-8722-3-26. J Hematol Oncol. 2010. PMID: 20678204 Free PMC article. Review.

5

IAP Antagonists Enhance Apoptotic Response to Enzalutamide in Castration-Resistant Prostate Cancer Cells via Autocrine TNF-α Signaling.

Pilling AB, Hwang O, Boudreault A, Laurent A, Hwang C. Pilling AB, et al. Among authors: hwang o, hwang c. Prostate. 2017 Jun;77(8):866-877. doi: 10.1002/pros.23327. Epub 2017 Feb 27. Prostate. 2017. PMID: 28240376

6

Targeting prosurvival BCL2 signaling through Akt blockade sensitizes castration-resistant prostate cancer cells to enzalutamide.

Pilling AB, Hwang C. Pilling AB, et al. Among authors: hwang c. Prostate. 2019 Aug;79(11):1347-1359. doi: 10.1002/pros.23843. Epub 2019 Jun 22. Prostate. 2019. PMID: 31228231 Free PMC article.

7

Pseudogene Associated Recurrent Gene Fusion in Prostate Cancer.

Chakravarthi BV, Dedigama-Arachchige P, Carskadon S, Sundaram SK, Li J, Wu KH, Chandrashekar DS, Peabody JO, Stricker H, Hwang C, Chitale DA, Williamson SR, Gupta NS, Navone NM, Rogers C, Menon M, Varambally S, Palanisamy N. Chakravarthi BV, et al. Among authors: hwang c. Neoplasia. 2019 Oct;21(10):989-1002. doi: 10.1016/j.neo.2019.07.010. Epub 2019 Aug 22. Neoplasia. 2019. PMID: 31446281 Free PMC article.

8

Androgen receptor negatively regulates mitotic checkpoint signaling to induce docetaxel resistance in castration-resistant prostate cancer.

Pilling A, Kim SH, Hwang C. Pilling A, et al. Among authors: hwang c. Prostate. 2022 Feb;82(2):182-192. doi: 10.1002/pros.24257. Epub 2021 Oct 21. Prostate. 2022. PMID: 34672379 Free PMC article.

9

Overcoming docetaxel resistance in prostate cancer: a perspective review.

Hwang C. Hwang C. Ther Adv Med Oncol. 2012 Nov;4(6):329-40. doi: 10.1177/1758834012449685. Ther Adv Med Oncol. 2012. PMID: 23118808 Free PMC article.

10

Chemotherapeutic inhibitors in the treatment of prostate cancer.

Deshmukh RR, Schmitt SM, Hwang C, Dou QP. Deshmukh RR, et al. Among authors: hwang c. Expert Opin Pharmacother. 2014 Jan;15(1):11-22. doi: 10.1517/14656566.2014.852184. Epub 2013 Oct 25. Expert Opin Pharmacother. 2014. PMID: 24156780 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,983 results

Search Page

Filters